Alexander Pasternak

4.3k total citations
88 papers, 2.5k citations indexed

About

Alexander Pasternak is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Alexander Pasternak has authored 88 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Virology, 42 papers in Infectious Diseases and 26 papers in Molecular Biology. Recurrent topics in Alexander Pasternak's work include HIV Research and Treatment (45 papers), HIV/AIDS drug development and treatment (29 papers) and HIV/AIDS Research and Interventions (22 papers). Alexander Pasternak is often cited by papers focused on HIV Research and Treatment (45 papers), HIV/AIDS drug development and treatment (29 papers) and HIV/AIDS Research and Interventions (22 papers). Alexander Pasternak collaborates with scholars based in Netherlands, United States and Belgium. Alexander Pasternak's co-authors include Ben Berkhout, Eric J. Snijder, Willy J. M. Spaan, Vladimir V. Lukashov, Margreet Bakker, Suzanne Jurriaans, Mary Struthers, Jan M. Prins, Gilles Darcis and Ralph Hirschmann and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Alexander Pasternak

86 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Pasternak Netherlands 30 1.2k 1.0k 690 438 399 88 2.5k
Albrecht von Brunn Germany 29 1.3k 1.1× 392 0.4× 1.1k 1.6× 313 0.7× 156 0.4× 48 2.8k
Brigitte Rosenwirth Austria 30 781 0.7× 899 0.9× 1.1k 1.6× 603 1.4× 54 0.1× 93 2.7k
Yan Xu China 29 651 0.6× 1.1k 1.1× 762 1.1× 1.1k 2.5× 89 0.2× 101 2.7k
Andrea Cuconati United States 31 873 0.7× 223 0.2× 1.2k 1.7× 542 1.2× 176 0.4× 52 3.5k
Vincent J. Merluzzi United States 17 762 0.6× 554 0.5× 558 0.8× 585 1.3× 55 0.1× 32 2.2k
Guangxiang Luo United States 39 594 0.5× 327 0.3× 1.3k 1.9× 433 1.0× 197 0.5× 75 4.3k
Yuntao Wu United States 29 1.3k 1.1× 1.6k 1.5× 1.0k 1.5× 1.0k 2.4× 48 0.1× 67 3.3k
S H Hughes United States 23 1.6k 1.4× 1.6k 1.5× 1.5k 2.2× 187 0.4× 45 0.1× 29 3.0k
Gwo‐Yu Chuang United States 25 408 0.3× 573 0.6× 1.2k 1.8× 443 1.0× 51 0.1× 44 2.0k
Georgios Pollakis Netherlands 29 1.1k 1.0× 1.7k 1.7× 685 1.0× 920 2.1× 31 0.1× 95 2.9k

Countries citing papers authored by Alexander Pasternak

Since Specialization
Citations

This map shows the geographic impact of Alexander Pasternak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Pasternak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Pasternak more than expected).

Fields of papers citing papers by Alexander Pasternak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Pasternak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Pasternak. The network helps show where Alexander Pasternak may publish in the future.

Co-authorship network of co-authors of Alexander Pasternak

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Pasternak. A scholar is included among the top collaborators of Alexander Pasternak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Pasternak. Alexander Pasternak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wenxuan, Ben Berkhout, & Alexander Pasternak. (2025). Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places. Current HIV/AIDS Reports. 22(1). 15–15. 1 indexed citations
2.
Boyd, Anders, Alexander Pasternak, Irma Maurer, et al.. (2025). Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption. AIDS. 39(7). 812–816. 1 indexed citations
3.
Dorman, Alexandra, Paolo Maiuri, Monika Bociąga‐Jasik, et al.. (2025). Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency. Nature Communications. 16(1). 2078–2078. 1 indexed citations
4.
Giron, Leila B., Alexander Pasternak, & Mohamed Abdel‐Mohsen. (2024). Soluble markers of viral rebound and post-treatment HIV control. Current Opinion in HIV and AIDS. 20(1). 61–69. 2 indexed citations
5.
Pasternak, Alexander & Ben Berkhout. (2023). HIV persistence: silence or resistance?. Current Opinion in Virology. 59. 101301–101301. 14 indexed citations
6.
Methot, Joey L., Xavier Fradera, Charles A. Lesburg, et al.. (2021). Identification of Potent Reverse Indazole Inhibitors for HPK1. ACS Medicinal Chemistry Letters. 12(3). 459–466. 24 indexed citations
7.
Vara, Brandon, Samuel M. Levi, David A. Candito, et al.. (2021). Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. ACS Medicinal Chemistry Letters. 12(4). 653–661. 31 indexed citations
8.
Darcis, Gilles, Ben Berkhout, & Alexander Pasternak. (2020). Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs. Viruses. 12(5). 489–489. 14 indexed citations
9.
Wang, Yun, Kelvin Zhang, Peter Georgiev, et al.. (2020). Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function. PLoS ONE. 15(12). e0243145–e0243145. 29 indexed citations
10.
Gharu, Lavina, Anna Kula, Alexander Pasternak, et al.. (2018). Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. mBio. 9(6). 30 indexed citations
11.
Pasternak, Alexander, Jan F. Prins, & Ben Berkhout. (2016). Cell-associated HIV-1 multiply spliced RNA level is an independent predictor of disease progression without ART and CD4:CD8 ratio normalization on ART. Journal of Virus Eradication. 2. 12–13. 1 indexed citations
12.
13.
Kiselinova, Maja, Alexander Pasternak, Ward De Spiegelaere, et al.. (2014). Comparison of Droplet Digital PCR and Seminested Real-Time PCR for Quantification of Cell-Associated HIV-1 RNA. PLoS ONE. 9(1). e85999–e85999. 126 indexed citations
14.
Pasternak, Alexander, Vladimir V. Lukashov, & Ben Berkhout. (2013). Cell-associated HIV RNA: a dynamic biomarker of viral persistence. Retrovirology. 10(1). 41–41. 90 indexed citations
15.
Felix, John P., Birgit T. Priest, Kelli Solly, et al.. (2012). The Inwardly Rectifying Potassium Channel Kir1.1: Development of Functional Assays to Identify and Characterize Channel Inhibitors. Assay and Drug Development Technologies. 10(5). 417–431. 5 indexed citations
16.
Tang, Haifeng, Zhe Feng, Lihu Yang, et al.. (2010). Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities. Bioorganic & Medicinal Chemistry Letters. 20(20). 6088–6092. 13 indexed citations
17.
Struthers, Mary & Alexander Pasternak. (2010). CCR2 Antagonists. Current Topics in Medicinal Chemistry. 10(13). 1278–1298. 72 indexed citations
18.
Pasternak, Alexander, Mary Struthers, Pasquale P. Vicario, et al.. (2009). Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist. ACS Medicinal Chemistry Letters. 1(1). 14–18. 25 indexed citations
19.
Yang, Lihu, Changyou Zhou, Liangqin Guo, et al.. (2006). Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3735–3739. 20 indexed citations
20.
Butora, Gabor, Gregori J. Morriello, Alexander Pasternak, et al.. (2006). 4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 16(18). 4715–4722. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albrecht von Brunn Breakdown of academic impact, for papers by Brigitte Rosenwirth Breakdown of academic impact, for papers by Yan Xu Breakdown of academic impact, for papers by Andrea Cuconati Breakdown of academic impact, for papers by Vincent J. Merluzzi Breakdown of academic impact, for papers by Guangxiang Luo Breakdown of academic impact, for papers by Yuntao Wu Breakdown of academic impact, for papers by S H Hughes Breakdown of academic impact, for papers by Gwo‐Yu Chuang Breakdown of academic impact, for papers by Georgios Pollakis
Rankless by CCL
2026